Building on these promising studies with ZFNs, several other efforts have developed similar gene-editing strategies to knockout CCR5 with TALENs,134,229 CRISPR/Cas9 (refs. 229, 230) and meganucleases.231 Other work has expanded beyond targeting only CCR5 to enhance resistance to HIV infection. This evidence concerns the gene CCR5 and HIV infectious disease.